[go: up one dir, main page]

ES2155782B1 - USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS. - Google Patents

USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.

Info

Publication number
ES2155782B1
ES2155782B1 ES009901036A ES9901036A ES2155782B1 ES 2155782 B1 ES2155782 B1 ES 2155782B1 ES 009901036 A ES009901036 A ES 009901036A ES 9901036 A ES9901036 A ES 9901036A ES 2155782 B1 ES2155782 B1 ES 2155782B1
Authority
ES
Spain
Prior art keywords
treatment
fermented milks
prepare fermented
transitorally
acidolactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009901036A
Other languages
Spanish (es)
Other versions
ES2155782A1 (en
Inventor
Amat Pere Pujol
Eric Postaire
Guardia Jose Antonio Mateos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danone SA Spain
Original Assignee
Danone SA Spain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009901036A priority Critical patent/ES2155782B1/en
Application filed by Danone SA Spain filed Critical Danone SA Spain
Priority to AU50695/00A priority patent/AU5069500A/en
Priority to ES00935083T priority patent/ES2238285T3/en
Priority to DK00935083T priority patent/DK1178730T3/en
Priority to PT00935083T priority patent/PT1178730E/en
Priority to AT00935083T priority patent/ATE291353T1/en
Priority to EP00935083A priority patent/EP1178730B1/en
Priority to PCT/EP2000/004593 priority patent/WO2000067583A2/en
Priority to DE60018919T priority patent/DE60018919T2/en
Priority to MXPA01011336A priority patent/MXPA01011336A/en
Publication of ES2155782A1 publication Critical patent/ES2155782A1/en
Application granted granted Critical
Publication of ES2155782B1 publication Critical patent/ES2155782B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Utilización de bacterias acidolácticas para preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos. La presente invención se refiere a una nueva utilización de bacterias acidolácticas para preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos, para la recuperación de niveles de actividad inmunitaria deprimidos con respecto al nivel que se puede considerar normal, sobre todo en individuos sanos sometidos a esfuerzos intensos o en general, a elevados niveles de solicitación fisiológica directamente producida por esfuerzos físicos o inducida por situaciones de tensión psíquica.Use of acid-lactic bacteria to prepare fermented milks for the treatment of transiently reduced levels of immune activity. The present invention relates to a new use of acid-lactic bacteria to prepare fermented milks for the treatment of transiently reduced levels of immune activity, for the recovery of depressed levels of immune activity with respect to the level that can be considered normal, especially in individuals. healthy subjected to intense efforts or in general, to high levels of physiological solicitation directly produced by physical efforts or induced by situations of psychic tension.

ES009901036A 1999-05-07 1999-05-07 USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS. Expired - Fee Related ES2155782B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ES009901036A ES2155782B1 (en) 1999-05-07 1999-05-07 USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.
DE60018919T DE60018919T2 (en) 1999-05-07 2000-05-05 USE OF MILK ACID BACTERIA IN THE MANUFACTURE OF FERMENTED DAIRY PRODUCTS FOR THE TREATMENT OF REDUCED IMMUNITY LEVELS
DK00935083T DK1178730T3 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria for the production of fermented milk products for the treatment of weakened immunity levels
PT00935083T PT1178730E (en) 1999-05-07 2000-05-05 USE OF LACTICAL ACID BACTERIA IN THE PREPARATION OF BREASTFEEDS FOR THE TREATMENT OF IMMUNITY LEVELS DEPRESSED
AT00935083T ATE291353T1 (en) 1999-05-07 2000-05-05 USE OF LACTIC ACID BACTERIA IN THE PRODUCTION OF FERMENTED MILK PRODUCTS TO TREAT REDUCED IMMUNITY LEVELS
EP00935083A EP1178730B1 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
AU50695/00A AU5069500A (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
ES00935083T ES2238285T3 (en) 1999-05-07 2000-05-05 USE OF ACIDOLACTIC BACTERIES IN THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF REDUCED IMMUNE LEVELS.
MXPA01011336A MXPA01011336A (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels.
PCT/EP2000/004593 WO2000067583A2 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901036A ES2155782B1 (en) 1999-05-07 1999-05-07 USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.

Publications (2)

Publication Number Publication Date
ES2155782A1 ES2155782A1 (en) 2001-05-16
ES2155782B1 true ES2155782B1 (en) 2002-05-16

Family

ID=8308409

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009901036A Expired - Fee Related ES2155782B1 (en) 1999-05-07 1999-05-07 USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.

Country Status (1)

Country Link
ES (1) ES2155782B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283027T3 (en) * 1996-11-29 2007-10-16 Bio K + International Inc. LACTIC FERMENT THAT INCLUDES A PARTICULAR CEPA OF LACTOBACILUS ACIDOFILUS AND USE OF THE SAME.
HU228046B1 (en) * 1997-08-21 2013-03-28 New Zealand Dairy Board Immunity enhancing lactic acid bacteria

Also Published As

Publication number Publication date
ES2155782A1 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
MX2012006628A (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion.
SI1562681T1 (en) Sock
MXPA03002957A (en) Use of probiotic lactic acid bacteria for balancing the skin's immune system.
MY136172A (en) Transparent absorbing article
IN2012DN02213A (en)
TW200637522A (en) Skin treatment articles and methods
SE9702860D0 (en) New use
AR028626A1 (en) USE OF L. CASEI IN IMMUNITY STIMULATING COMPOSITIONS
MX2012006629A (en) Probiotic microorganisms as active agents against changes in the skin's microrelief.
AR021643A1 (en) COMBINATION OF CERIVASTATIN AND FIBRATES.
RS89204A (en) Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
TR200200301T2 (en) Bifidobacteria suitable to kill diarrhea caused by pathogenic bacteria
MX2007005587A (en) Novel composition for easing human child birth.
MXPA05007438A (en) Absorbent article having improved softness.
BR0209541A (en) Use of 2-phenyl-substituted imidazotriazinones
ZA202103181B (en) Reduction of pathogenic bacteria using arginine
GT199600075A (en) ABSORBENT ARTICLE WITH ADAPTABLE GRIPS.
ES2155782B1 (en) USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS.
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
GT200200164A (en) METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA
EA200601238A1 (en) MEDICATIONS FOR PREVENTION AND TREATMENT OF BROMIDROSIS AND TO IMPROVE THE ODOR OF THE BODY
BR0115534A (en) Isolated luciferases as well as their employment
ATE474582T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GLUCAN FROM MICROALGAE
PT1212119E (en) USE OF CIAMEMAZINE IN THE TREATMENT OF BENZODIAZEPINES SUBMITTED WEAR
EA200200704A1 (en) IMMEDIATE MICROORGANISMS FOR THE TREATMENT OF INFECTION

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516

FD2A Announcement of lapse in spain

Effective date: 20180807